Health
Comparison of oral vs intravenous etoposide in the management of small‐cell lung cancer: A real‐world, population‐based study – MD Linx
MDLinx original journal summary on Lung Cancer, Pulmonology from The Clinical Respiratory Journal
For firstline treatment in smallcell lung cancer (SCLC), researchers assessed whether PO vs IV etoposide is useful in combination with a platinum agent (cisplatin/carboplatin) in this study including 2,066 patients with SCLC. Based on stage, patients were divided as limited disease and extensive disease. Route of etoposide administration, dose reductions and vital status was evaluated in chemotherapy naïve patients receiving one cycle of combination chemotherapy. Findings revealed similar overal…
-
General24 hours agoFire razes Tumby Bay hardware store with damage likely to exceed $1m
-
General24 hours agoDonald Trump and the ghost of Al Capone • Inside Story
-
Noosa News23 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
Noosa News8 hours agoExcellence awards nominations received – Proctor